Abstract:A simple extraction followed by an LC‐MS/MS method is presented to effectively screen for pregabalin and metformin, in addition to more than 150 other compounds of interest in equine and canine urines. The prevalence of pregabalin and metformin in race‐day urine samples in Western Australia was monitored using this method over 12 months. More than 4000 equine and canine urine samples were screened, and four samples were confirmed positive for these substances. Positive identification and reporting of therapeutic substances intended for human consumption in race‐day equine and canine samples is a controversial topic. While inadvertent environmental exposure is a potential cause for the presence of these substances in race‐day samples, intentional use cannot be ruled out given their therapeutic benefits. Pregabalin is widely prescribed in Australia to treat epilepsy, anxiety, and neuropathic pain in humans; however, it is also increasingly used as a recreational drug. Metformin is commonly used to treat type 2 diabetes in humans. Both pregabalin and metformin have no routine use on racing animals and should not be present in race‐day samples taken from healthy animals. They are prohibited substances under the Rules of Racing with no established screening limits. Although therapeutic levels for these substances have been established in humans, such information is not available for animals. Pregabalin and metformin are analytically challenging molecules, more so when they are extracted from biological matrices routinely screened for hundreds of other compounds simultaneously. A simple extraction, followed by a targeted Ultra High‐Pressure Liquid Chromatography OrbitrapTM Mass Spectrometry method utilising a reverse‐phase C18 column, is presented. This method is effective in screening for pregabalin and metformin, in addition to more than 150 other compounds of interest in equine and canine urines. The prevalence of pregabalin and metformin in race‐day equine and canine urine samples in Western Australia was monitored using this method over 12 months. More than 4000 urine samples were screened, and four samples were confirmed positive for these substances.

Broad‐spectrum and sensitive screening of more than 1000 compounds in equine urine using liquid chromatography/high‐resolution mass spectrometry

A Broad-Spectrum Peptide Screening Method Using an Optimized Solid-Phase Extraction and Liquid Chromatography–High-Field Asymmetric Ion Mobility Spectrometry–Mass Spectrometry for Doping Control in Equine Urine

Development and validation of general plasma screening method for performance enhancing drugs in racehorses utilizing liquid chromatography-high-resolution mass spectrometry (LC-HRMS)

Non-Targeted Detection of Synthetic Oligonucleotides in Equine Serum Using Liquid Chromatography–High-Resolution Mass Spectrometry

Method Development and Validation for Simultaneous Detection of Corticosteroids, Small Peptides, SARMs and Quaternary Ammonium Drugs in Camel Urine for Doping Control Applications

Direct injection horse urine analysis for the quantification and identification of threshold substances for doping control. III. Determination of salicylic acid by liquid chromatography/quadrupole time-of-flight mass spectrometry

Multi-detection of corticosteroids in sports doping and veterinary control using high-resolution liquid chromatography/time-of-flight mass spectrometry

Emerging Human Medications in Racing Animals: Analytical and Regulatory Challenges

Efficient use of retention time for the analysis of 302 drugs in equine plasma by liquid chromatography-MS/MS with scheduled multiple reaction monitoring and instant library searching for doping control

A rapid and sensitive method for the quantitative analysis of ibuprofen and its metabolites in equine urine samples by gas chromatography with tandem mass spectrometry.

Quantification of osilodrostat in horse urine using LC/ESI-HRMS to establish an elimination profile for doping control

Metabolic Pathway of Osilodrostat in Equine Urine Established through High-resolution Mass Spectrometric Characterization for Doping Control

A Multi-Class, Multi-Residue Method for Detection of Veterinary Drugs in Multiple Meat Using a Pass-Through Cleanup SPE Technique and UPLC-MS/MS Analysis

Detection of FG‐4592 and metabolites in equine plasma, urine and hair following oral administration

A Comprehensive and High-Throughput Screening Multiple Prohibited Substances Method by UPLC-QE Plus-HRMS and HPLC-QQQ-MS in Human Urine for Doping Control

Development and validation of an open screening method for diuretics, stimulants and selected compounds in human urine by UHPLC–HRMS for doping control

Analysis of corticosteroids in equine urine by liquid chromatography–mass spectrometry

Pharmacokinetic study of osilodrostat and identification of mono‐hydroxylated metabolite in equine plasma for the purpose of doping control

Multi-analyte screening of small peptides by alkaline pre-activated solid phase extraction coupled with liquid chromatography-high resolution mass spectrometry in doping controls

Doping Control Analysis of Perfluorocarbons in Equine Plasma by Headspace Gas Chromatography‐Tandem Mass Spectrometry